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Summary The expression of heat shock proteins (HSP) of the 65kD family (groEL) has been observed by
flow cytometry using murine monoclonal antibody (MoAb) anti-HSP 65kD (ML30) on the surface of B
(Daudi) or T (H9) lymphoma cells, on a moncyte cell line (U937) and also on a primary culture of a human
pancreatic carcinoma (HPC). Moreover, the MoAb ML30 was coupled to Saporin 6, a ribosome-inactivating
protein recovered from the seeds of Saponaria officinalis, to kill HSP-expressing cells with a specific
immunotoxin. An indirect method using first MoAb ML30 and then anti-mouse IgG, immunotoxin was also
performed. With this method a human serum positive for HSP65-antibodies was tested using anti-human IgG,
or IgM immunotoxins.
All cell lines were inhibited when preincubated with the specific immunotoxin directed to HSP65 (ML30
S06), although H9 cells were susceptible to immunotoxin only after thermal stress. Daudi and HPC cells were
inhibited both after long-term culture and when freshly explanted from SCID mice. Proliferation of the U937
monocytic cell line, that constitutively expresses high levels of HSP65 on the surface (as determined by flow
cytometry), was completely inhibited (100% inhibition) by the ML30 S06. However, not all tumour cells
constitutively express high levels of surface HSP65, as determined by cytometric analysis. For this reason it
was not always possible to obtain complete inhibition of cellular proliferation.
Heat Shock Proteins (HSP) represent a family of highly
conserved molecules that under stress conditions play an
important physiological role in folding and unfolding of
proteins (Lindquist & Craig, 1988). HSP expression is strictly
related to cell cycle and oncogene activation (Pechan, 1991),
and it is important to note that HSP are often tumour
associated antigens (Ulrich & Robinson, 1986; Srivistava &
Maki, 1990). In fact, myc-overexpressing cells show viral
myc-proteins nuclearly colocalised with nuclear HSP70
(Koshinen et al., 1991). The myc-oncogene is functionally
similar to the adenovirus Ela and is able to collaborate with
activated ras-oncogene to transform primary fibroblasts
(Ralston, 1991). It has been reported also that the adenoviral
Ela products induce HSP70 synthesis by acting as transcrip-
tional activator. However, it is not yet clear whether in-
creased levels of HSP may facilitate tumoural and viral pro-
liferation. In Hela cells, HSP70 interacts with other cellular
proteins in a cell cycle-dependent manner; synthesis of HSP
has been shown to increase during mitosis (Pechan, 1991).
Other HSP such as HSP90 and HSP70 have been found to
reach abnormally high levels in transformed cells (Bensaude
& Morange, 1983). Proteins belonging to the HSP70 family
were shown to interact with nuclear oncogenes such as p53,
and the stability of this interaction might influence transfor-
mation (Finlay et al., 1988). It was also found that high
HSP65 expression was not a general feature of all trans-
formed cells, since some cell lines expressed little or non
detectable HSP65 protein, while TNF-a and/or IFN--y are
able to increase synthesis of HSP in tumour cells (Ferm et
al., in press).
Surface expression of HSP is still controversial; some authors
have found no evidence for cell surface expression (Ferm et
al., in press), whereas others reported cell membrane HSP
expression during infection with transforming viruses (La
Thangue & Latchman, 1988; Newins, 1982). We recently
reported that H9 cells chronically infected with HIV-1 ex-
press membrane HSP70 (Di Cesare et al., in press). During
these studies, we observed that anti-HSP65 and HSP70
monoclonal antibodies were able to mediate antibody depen-
dent cellular cytotoxicity (ADCC) against a large panel of T
and B cell lymphomas using human peripheral lymphocytes
as effector cells (Poccia et al., submitted).
The objectives of the present study have been mainly to
obtain direct evidence that HSP are expressed on the memb-
rane of tumour cells and secondly to evaluate the practical
possibility of using HSP as target for immunotoxins. We
developed indirect and direct anti-HSP immunotoxin
reagents and methodologies to kill tumour cells using HSP as
a molecular target. Moreover, we have investigated the pos-
sibility of inhibiting human cell lines obtained from long
term cultures and also freshly explanted from SCID mice.
Materials and methods
Cell lines and induction ofHSP
Daudi cells derive from a Burkitt lymphoma, U937 cells are
characterised as a monocytic cell line, and H9 is a CD4+
lymphoma cell line. Human pancreatic carcinoma (HPC)
cells were obtained from a primary culture. Cells were cul-
tured in RPMI-1640 medium, supplemented with 10% inac-
tivated foetal calf serum, 1% L-glutamine and antibiotics at
a starting concentration of 2 x 105ml-', and subsequently
split when cell concentration was higher than 106mI-1 (twice
a week).
To increase the constitutively low expression of surface
HSP on H9 line, cells were resuspended at a concentration of
5 x 105ml-' in preheated culture medium and kept at 45°C
for 15min. Cells were then centrifuged, resuspended at the
same concentration in medium at 37°C and normally
incubated at 37°C and 5% CO2 for 24h before use in
cytotoxic, proliferative or cytofluorimetric analyses.
SCID mice
The SCID mutation (Bosma et al., 1983) occurred in the
C.B-171cr (C.B-17) inbred strain, an immunoglobulin heavy
chain (Igh) congenic partner strain of BALB/cAnIcr (BALB/
c). These mice have a severe combined immune deficiency as
a result of their inability to rearrange correctly their
immunoglobulin and T-cell receptor genes, and for this
reason are permissive for the growing of transformed human
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cell lines (Moisier et al., 1988). The SCID mice used in these
experiments were bred by Cave-Tech (Rome) and injected
with Daudi (107 cells i.p.) or HPC cells (107 cells s.c.). After
7-14 days, visible solid (HPC) and ascitic (Daudi) tumours
were collected and the cells were immediately tested for HSP
expression.
Monocolonal antibody (MoAb) and human serum against
HSP
The MoAb ML30 recognises the amino acids 275-295 of the
65kD HSP from M. leprae and M. tuberculosis and, with less
affinity, other species of mycobacteria. It was also reported
that this MoAb cross-reacts with human HSP65 and belongs
to the IgG, class (Ivanyi et al., 1983; Evans et al., 1990). All
cell lines used in this study were checked for mycobacteria
contamination by culturing cell line extracts on Sauton
medium.
Human sera obtained from healthy donors (Munk et al.,
1989) were selected by their positivity for antibodies against
human HSP65 by Western blotting, and one positive human
serum was used to mediate cytotoxic activity against HSP
(Poccia et al., submitted).
Immunotoxin
The ribosome-inactivating protein saporin 6 was prepared as
previously described (Stirpe et al., 1992) from seeds of
Saponaria officinalis (kindly supplied from the Azienda
Regionale delle Foreste, Regione Emilia-Romagna,
Bologna). This protein has the ability to inactivate proteic
synthesis cleaving the ribosomal RNA in correspondence of a
specific adenine in a highly conserved r-RNA region (adenine
4324 of rat liver r-RNA).
The protein was labelled with 1251I (lodogen reagent,
Pierce). Saporin was linked to antibodies as previously des-
cribed (Bolognesi et al., 1989) by an artificial disulfide bin-
ding introduced with 2-iminothiolane. Briefly, antibodies
(ML30, anti-human IgG and IgM, and anti-tenascin BC2) or
F(ab')2 fragments of anti-mouse IgG (Sigma, St Louis, MO,
USA) and saporin, the latter containing a trace of 1251I
saporin, were dissolved in 50mM borate buffer pH9.0 at a
concentration of lmgml-' and 6mgml-', respectively, and
were modified with 2-iminothialane (2-IT) at a final concent-
ration 0.6mM (antibodies or 0.8-1.0mM (saporin). After
30min at room temperature (22°C), glycine was added to a
final concentration at 200mM. After 30min, Ellman's reagent
dissolved in 50fd of dimethylformamide was added to a final
concentration 2.5mM, and modified proteins were separated
from unreacted reagents by gel filtration on a Sephadex-G25
column. The modified saporin was reduced with 50mM 2-
dithiothreitol, filtered through a Sephadex G-25 column and
mixed with the unmodified antibodies in a saporin ratio of
10: 1. After 24h, the conjugate was separated from unreacted
components by gel filtration on a Sephacryl S200 high resolu-
tion column. The Saporin/antibody ratio of immunotoxins
was calculated from the radioactivity. The inhibitory activity
on -protein synthesis was assayed, after reduction of 2-
dithiothreitol, on a rabbit reticulocyte lysate as described
(Bolognesi et al., 1989). Murine MoAb BC2 (anti-tenascin)
coupled with saporin was used as immunotoxin control. The
concentration providing 50% inhibition of protein synthesis
in a rabbit reticulocyte system (Bolognesi et al., 1989) were
3.8, 5.13, 7.59, 2.58 and 2.88ngmlh' for immunotoxins
derived from the following antibodies: ML30, anti-human
IgM, anti-human IgG, anti-mouse IgG and BC2 respectively;
the molarity ratio between antibodies and saporin was 1.87,
3.50, 5.50, 3.13 and 2.20, respectively.
Immunofluorescence analysis
All tumour cell lines were analysed by an indirect
immunofluorescence method using the MoAb anti-HSP65
ML30. Cell suspensions were left in PBS for analysis of
membrane immunofluorescence. Cells resuspended in 1001l
of PBS with 1% FCS were incubated with the S't antibody
(ML30) for 30min at 4°C. Cells were then centrifuged,
washed twice and incubated for 30min in presence of the 2nd
antibody consisting of FITC-conjugated goat anti-mouse
IgG, (GAM -Zymed). Analysis was performed using a flow
cytometer (FACScan, Becton Dickinson).
Immunotoxin cytotoxicity
Cytotoxic activity was evaluated by the classical 5"Chromium
release technique. In brief 2 x 106 target cells were
resuspended in 1001l of medium, labelled with 100ICi51Cr
(NEN Research Products) and incubated for 1 h at 37°C and
5% CO2. Cells were then washed extensively and incubated
in the presence or absence of antibodies (ML30 or HSP65
positive human serum) for 30min at 37°C before the addition
of immunotoxin (anti-mouse IgG S06 or anti-human IgG/
IgM S06). Each well was loaded with 50il of target cells
(104 cells), 50p1l of antibodies (ML30, lOOgmt1-) and 100yl
of immunotoxin at different concentrations. All samples were
run in triplicate. The plates were centrifigued at 80g for 5min
and then incubated for 18h at 37°C and 5% CO2. After
centrifugation for 5min at 80g at 4°C, 1001l samples of the
supernatants were distributed in 5ml-tubes, and radioactivity
was measured using a y-counter (Beckman gamma 5500).
The percentage of cytotoxicity was calculated according to
the following formula:
Cpm maximum release - Cpm spontaneous release
Cpm sample release - Cpm spontaneous release x 100
The spontaneous release was obtained from aliquots taken
from wells containing only target cells labelled with 5"Cr. The
maximum release was obtained from wells containing
labelled target cells and saponin as lysing reagent. The stan-
dard deviation between the triplicates in all tests was less
than 10%
Immunotoxin dependent inhibition ofcellularproliferation
Cell proliferation was evaluated using a 3H-thymidine incor-
poration technique (Barbieri et al., 1989). 102 target cells
were resuspended in 100,lI of medium and 100tly of
immunotixin at different dilutions (1-03-10-7M) were added.
For the indirect immunotoxin assay, cells were incubated in
presence or absence of ML30 (100flgml-') for 30min at 4°C
and washed before the addition of anti-mouse immunotoxin.
For the direct immunotoxin assay, the cells were incubated
with the anti-HSP65 immunotoxin for 30min at 4°C and then
washed. After 90h of incubation at 37°C (control cells were
still in logarithmic growth), cells were incubated for 6h with
3H-thymidine (0.5pCi/well, Amersham), harvested and
radioactivity measured using a P-counter.
Statistical analysis
Student's t-test was performed for analysis of the means. Cell
proliferation inhibition assay was analysed using linear
regression.
Results
HSP65-specific immunofluorescence on tumour cell lines
The presence of membrane HSP65 has been analysed by flow
cytometry using the antiHSP65 MoAb ML30 on T (H9) and
B (Daudi) cell lymphomas, on a monocytic cell line (U937)
and on HPC, a human pancreatic carcinoma cell line. Table I
illustrates the specific fluorescence in the presence of anti-
HSP65 MoAb and the fluorescence of the negative control
cells stained only with the FITC-conjugated anti-mouse IgG.
Daudi, U937 and HPC cells constitutively expressed
significant levels of HSP65, while HSP membrane expression
on normal H9 was low. However, heat shock treatment of
H9 cells increased membrane HSP65 expression.HSP SURFACE EXPRESSION AND IMMUNOTOXINS 429
Table I FACS analysis of HSP65 cell surface expression
% ofpositive cells
Cell anti-IgG FITC bindinga ML30 bindingb
H9 1.3 21.4
H9 + h.shock 14.7 52.0
Daudi 0.1 42.7
U937 0.3 90.6
HPC 0.2 22.0
aSurface staining in presence only of the second antibody
(anti-murine IgG FITC). bSurface staining after incubation with first
ML30 and second anti-murine IgG FITC.
Killing ofH9 and Daudi cells by anti-HSP65 antibodies, using
anti-mouse IgG or anti-human IgG/IgM immunotoxins
HSP65 membrane expression in tumour cells and related cell
killing was then investigated using the classical 5'Cr-release
assay. Figure 1 shows that approximately 30% of heat-
stressed H9 cells (grey bar), could be killed by saporin-
coupled anti-mouse IgG (anti-mIgG S06) when preincubated
with murine anti-HSP65 MoAb. Unstressed cells (black bar)
were less affected by this treatment, and anti-mIgG S06
alone did not cause any significant killing of either stressed
or unstressed cells.
Anti-human MoAbs coupled with saporin were used to
determine the presence of anti-HSP65 antibodies in a human
serum shown by western blotting to contain anti-HSP
antibodies. Figure 2 shows a marked increase in cytotoxicity
when target cells (Daudi) had been treated with the positive
human serum and subsequently with anti-human IgM (black
bar) or IgG, (grey bar) immunotoxins. In both figures, the
maximum killing was observed at 10" and 10-9M
immunotoxin dilutions corresponding with the data from
immunoprecipitation curves.
Inhibition oftheproliferation ofdistinct tumour cell lines by
saporin-coupled ax-HSP65 MoAb
The effect of S06-coupled ML30 antibody on U937
monocytic cell proliferation was analysed since U937 cells
constitutively express high levels of HSP65 on the surface (as
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Figure 1 Cytotoxic effect of anit-HSP65 MoAb (ML30) on un-
treated and heat treated H9 cells incubated with anti-mouse IgG,
conjugated with saporin (a-mIgG S06). No significant differences
were observed between normal H9 cells treated (black bar) or
untreated (striped bar) with ML30. In contrast, approximately
30% of heat stressed H9 cells could be killed (P<0.05) when
cells were preincubated with anti-HSP65 MoAb at 10-13 and
10-1 saporin molarity (grey bar).
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Figure 2 cytotoxic effect of human serum (HS) containing anti-
HSP antibodies on Daudi cells incubated with anti-human IgM
(black bar) or anti-human IgG, (grey bar), coupled with saporin
(ahIgG S06 and x-hIgM S06 respectively). Significant differences
(P<0.05) were observed when cells were preincubated with
human serum at l0-13, 10-12 and 10-li saporin molarity (black
and grey bar).
determined by flow cytometry). Figure 3 (panel a) shows a
complete inhibition (98%) of cell proliferation. A similar
experiment was performed with Daudi cells, and Figure 3
(panel b) shows a 60% inhibition of cell proliferation in the
presence of either direct or indirect immunotoxin (10-8 and
10-7M), while neither free saporin, nor saporin plus free
ML30 or BC2 S06 were able to inhibit lymphoma cell
proliferation.
Further experiments were performed on U937 and Daudi
cells, leaving free toxin or ML30 S06 in culture for 72h (in
contrast to all experiments described above where immuno-
toxins were kept in culture only for 1 h and then washed as
reported in M&M). As seen in Figure 3, free toxin left in
culture for 72h exerted s strong inhibition of U937 (panel c)
and Daudi (panel d) proliferation, thus causing difficulties in
evaluation of the specific inhibition due to the
immunotoxin.
In the following experiment, H9 cells, either unstressed
(Figure 4, panel a) or heat-stressed (panel b) were incubated
for 1 h with ML30 S06, washed extensively and then cultured
for 90h. As may be seen, thymidine incorporation of heat-
stressed H9 cells was inhibited by HSP-specific immunotoxin,
but not by free saporin or saporin plus free ML30 or BC2
S06.
Effect ofanti-HSP65 immunotoxin on ex vivo tumour cells
Experiments were performed to obtain direct evidence that
tumour cells freshly collected ex vivo are susceptible to the
inhibitory activity of anti-HSP65 immunotoxin. Daudi and
HPC cells were injected into SCID mice; after 15-20 days,
when ascites or solid tumour could be observed, cells were
harvested from animals and immediately tested with anti-
HSP65 immunotoxin in the cell proliferation assay. Figure 5
shows that the proliferation of cells either cultured in vitro or
freshly collected ex vivo was inhibited by the anti-HSP65
immunotoxin.
Discussion
Although the presence of HSP in the intracytoplasmatic and
nuclear compartments is well documented (Lindquist &
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Figure 4 Inhibition of cell proliferation of normal (panel a) or
heat stressed (panel b) H9 cells mediated by ML30 S06. No
significative differences were observed between any of the groups
in panel a. Significant differences (P<0.05-0.001) were observed
when heat-stressed H9 cells (panel b) were treated with anti-
HSP65 immunotoxin at 10-11-10-i saporin molarity.
Craig, 1988), little information is available so far on HSP
membrane expression. The membrane localisation of HSP
was observed directly by immunofluorescence on activated
mononuclear phagocytes (Wurttenberg et al., 1991) and in
the course of viral infections (La Thangue & Latchman,
1988), and indirectly by the fact that TT/6 lymphocytes recog-
nises HSP on Daudi cells (Fish et al., 1990). In this context,
HSP recognition might represent a mechanism for the role of
HSP in autoimmunity and microbial infections (Kaufmann,
1990).
We recently reported that human lymphoma cells express
membrane HSP70 and HSP65 representing a molecular
target for antibody dependent cellular cytotoxicity (Poccia et
al., submitted). This observation prompted us to investigate
the use of immunotoxins directed towards the molecular
target of HSP expressed in tumour cells.
There is direct correlation between immunofluorescence
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Figure 3 Inhibition of cell proliferation in U937 and Daudi cell
lines. The panel a shows the inhibition of U937 cell proliferation
mediated by saporin coupled ML30, and with the same MoAb
using also the anti-murine IgG immunotoxin (a-mIgG S06).
Significant differences were observed when U937 cells were
treated with ML30 immunotoxin at 10-8 (P<0.05) or at l0-'
(P<0.00l) saporin molarity. Panel b shows inhibition of Daudi
cell proliferation by saporin coupled anti-HSP65 MoAb (ML30
S06), and with the same MoAb using also the anti-murine IgG
immunotoxin (x-mIgG S06). Free saporin, free saporin plus
uncoupled ML30, anti-murine IgG immunotoxin (a-mIgG S06)
or irrelevant anti-tenascin immunotoxin (BC2 S06) were used as
negative controls. Significant differences (P<0.001) were
observed with the ML30 S06 and with the ML30 and a-mIgG
S06 too, at 10-8 and 10-7 saporin molarity. ML30 alone does
not cause any inhibition of cell proliferation (105% panel a 89%
panel b). Inhibition of cell proliferation in U937 and Daudi,
using ML30 S06 left in culture for the whole incubation, is
shown in panels c and d respectively. It may also be seen that free
toxin (left in culture for 72h) exerts a strong inhibition.
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Figure 5 Inhibition of cell proliferation of Daudi (panel a) and
HPC (panel b) also, either in vitro cultured or on ex vivo. Linear
regression analysis showed similar sensitivity of Daudi cells either
in vitro (r = 0.79) or ex vivo (r = 0.83) and of HPC cells either in
vitro (r = 0.90) or ex vivo (r = 0.85).
and sensitivity to anti-HSP immunotoxins. In particular, un-
stressed H9 cells which do not express membrane HSP65 are
not inhibited by immunotoxins, while heat-shocked H9 cells
show positive reaction in membrane immunofluorescence as
well as sensitivity to immunotoxin cytotoxicity and inhibition
of cell proliferation. Similarly, Daudi and U937 cells, consti-
tutively expressing high levels of membrane HSP65, show up
to 98% inhibition of cell proliferation.
The specificity of HSP65 immunotoxin effects on Daudi, H9,
and U937 cells is clearly documented by the lack of cell
proliferation inhibitory activity when only free saporin,
saporin plus uncoupled anti-HSP65 or irrelevant (BC2)
immunotoxin were used. The efficiency of saporin-coupled
immunotoxins either as anti-HSP65 (direct immunotoxin) or
anti-human/mouse Ig (indirect immunotoxins) on all tumour
lines tested so far is clearly indicated by the fact that saporin-
conjugates are easily internalised (Tazzari et al., 1988). This
fact can be correlated with the observation that saporin-
coupled anti-CD4 and CD8 antibodies inhibit human lym-
phocyte proliferation (Barbieri et al., 1989). Development of
immunotoxin methodology is mainly limited by tumour
antigen specificity. In this context, the broad specificity of
anti-HSP immunotoxin might be to advantage, although cell
lines expressing little or no HSP do not appear to be suscep-
tible to killing in this system. However, TNF or other
cytokines (Ferm et al., in press) are able to increase HSP
synthesis in tumour cells, and this may be one way to in-
crease immunotoxin activity.
Membrane HSP expression by tumour cells may be con-
sidered a phenomenon of in vitro cultured cells. For this
reason we transplanted Daudi and HPC cells in SCID mice
and tested the explanted cells for HSP expression immedi-
ately after removal from the animals. Our results showed
that such tumour cells express HSP65 in vivo and can be
inhibited by immunotoxin. Thus, the human/SCID model
may be helpful to evaluate the immunotoxin approach in
vivo, considering also the lack of immune response against
toxin in this strain of mice. Preliminary experiments in vivo,
where human HPC cells have been growing subcutaneously
in SCID mice, showed that daily s.c. injection of anti-HSP65
immunotoxin leads to tumour reduction after one week of
treatment (Poccia et al., in preparation).
Several saporin-containing immunotoxins against specific
cell antigens have been prepared. Besides those quoted above
(Tazzari et al., 1989; Barbieri et al., 1989), an anti-CD30-
saporin immunotoxin was shown to be highly effective on
Reed-Sternbery-derived cells used as target in vitro (Tazzari
et al., in press). Moreover, it was also effective when admini-
stered in vivo to patients with Hodgkin's lymphoma (Falini et
al., in press). Present results show that an anti-HSP65-
saporin immunotoxin may recognise transformed cells, thus
suggesting that it might be possible to develop immunotoxins
active against a large panel of tumour cells, in contrast to
immunotoxins recognising only specific single tumours.
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